Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies

por Venerito, Marino, Wex, Thomas, Malfertheiner, Peter
Publicado 2010

The Pancreas: Causes for Malabsorption

por Hackert, Thilo, Schütte, Kerstin, Malfertheiner, Peter
Publicado 2014

Anatomy-shaped design of a fully-covered, biliary, self-expandable metal stent for treatment of benign distal biliary strictures

por Weigt, Jochen, Kandulski, Arne, Malfertheiner, Peter
Publicado 2016

Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy

por Malfertheiner, Peter, Ripellino, Claudio, Cataldo, Nazarena
Publicado 2018

Treating critically ill patients with probiotics: Beneficial or dangerous?

por Jacobi, Christoph A, Schulz, Christian, Malfertheiner, Peter
Publicado 2011

Whipple's Disease

por Obst, Wilfried, von Arnim, Ulrike, Malfertheiner, Peter
Publicado 2014

Medical and Surgical Conditions for the Treatment of Malabsorption

por Kadmon, Martina, Schütte, Kerstin, Büchler, Markus, Malfertheiner, Peter
Publicado 2014

Modified Helicobacter test using a new test meal and a (13)C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors

por Tepeš, Bojan, Malfertheiner, Peter, Labenz, Joachim, Aygen, Sitke
Publicado 2017

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond

por Schulz, Christian, Schütte, Kerstin, Mayerle, Julia, Malfertheiner, Peter
Publicado 2019

Maintenance Therapy with FOLFIRI after FOLFIRINOX for Advanced Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis

por Franck, Caspar, Canbay, Ali, Malfertheiner, Peter, Venerito, Marino
Publicado 2019

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors

por Franck, Martin, Schütte, Kerstin, Malfertheiner, Peter, Link, Alexander
Publicado 2020

Implications of growth factor alterations in the treatment of pancreatic cancer

por Juhász, Márk, Nitsche, Barbara, Malfertheiner, Peter, Ebert, Matthias PA
Publicado 2003

STW 5 (Iberogast(®))—a safe and effective standard in the treatment of functional gastrointestinal disorders

por Ottillinger, Bertram, Storr, Martin, Malfertheiner, Peter, Allescher, Hans-Dieter
Publicado 2012

A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?

por Januszewicz, Wladyslaw, Turkot, Maryla Helena, Malfertheiner, Peter, Regula, Jaroslaw
Publicado 2023

A proposal for a new clinical classification of chronic pancreatitis

por Büchler, Markus W, Martignoni, Marc E, Friess, Helmut, Malfertheiner, Peter
Publicado 2009

Serological assessment of gastric mucosal atrophy in gastric cancer

por Bornschein, Jan, Selgrad, Michael, Wex, Thomas, Kuester, Doerthe, Malfertheiner, Peter
Publicado 2012

Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer

por Link, Alexander, Becker, Verena, Goel, Ajay, Wex, Thomas, Malfertheiner, Peter
Publicado 2012

Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function

por Franck, Martin, Thon, Cosima, Schütte, Kerstin, Malfertheiner, Peter, Link, Alexander
Publicado 2020

Editorial: Helicobacter pylori infection: pathogenesis, antibiotic resistance, advances and therapy, new treatment strategies

por Mascellino, Maria Teresa, Pontone, Stefano, Vega, Alba Edith, Malfertheiner, Peter
Publicado 2022

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome

por von Arnim, Ulrike, Wex, Thomas, Ganzert, Christine, Schulz, Christian, Malfertheiner, Peter
Publicado 2016